Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
21 January 2020
GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update
20 January 2020
GenSight Biologics Announces its 2020 Financial Calendar
20 December 2019
GenSight Biologics Announces the Filing of its 2018 Universal Registration Document
20 December 2019
GenSight Biologics obtains €15 million in financing through a bond issuance from Kreos Capital and a reserved capital increase from Sofinnova and 3SBio
11 December 2019
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history
09 December 2019
The Quinze-Vingts Hospital and GenSight Biologics announce a first Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France
22 October 2019
GenSight Biologics Reports its Cash Position as of September 30, 2019 and Provides Operational Update
09 October 2019
GenSight Biologics reports evidence of GS010 DNA transfer to contralateral eye of primates unilaterally injected with GS010 Gene Therapy
08 October 2019
GenSight Biologics Appoints Magali Taiel as Chief Medical Officer
08 October 2019
GenSight Biologics to present new GS010 data at the 2019 Annual Meeting of the American Academy of Ophthalmology
View previous 9 articles
1
…
10
11
12
13
14
15
16
17
18
19
20
…
24
View next 9 articles
Go back to the page of the page